Ethicare began trading on 1 July 2019 from Healthcare Park in Woodmead, Sandton as a division of Pharmacare Limited.
This division was formed following a strategic review of Aspen’s South African Commercial Pharma business with the express intent of achieving heightened product and customer focus across a broad range of pharmaceutical brands.
Ethicare’s portfolio comprises more than 240 brands, valued at approximately R2.4 billion across both the private and public sectors. This portfolio covers various therapeutic categories including, but not limited to anticoagulants, anti-infectives, anti-inflammatories, antiretrovirals, cardiovascular, central nervous system, respiratory and thrombotics. Ethicare will operate under the Pharmacare Limited pharmaceutical license.
Ethicare’s team comprise highly skilled resources who cover a full suite of commercial competencies and who will ensure optimal business efficiencies and continuity for our customers.
While Ethicare has adopted its own corporate identity and tagline, ‘Committed to caring’, this division subscribes to Aspen’s values of teamwork, integrity, commitment, excellence and innovation as well as its vision “To deliver value to all our stakeholders as a responsible corporate citizen that provides high quality, affordable medicines and products globally.”
Every effort has been made to seamlessly integrate Ethicare into Pharmacare Limited and we look forward to enjoying a continued long-standing and mutually prosperous relationship with our stakeholders.
Should you have any queries about Ethicare in the interim, please direct them to email@example.com.